Aducanumab: A Deep Dive into BIIB037 and its Impact A drug, initially known as BIIB037, constitutes a complex attempt to treat emerging Alzheimer's condition. Created by Biogen, aducanumab acts by removing amyloid https://www.targetmol.com/compound/aducanumab